HBSAG LOSS WITH TENOFOVIR DISOPROXIL FUMARATE PLUS PEGINTERFERON ALFA-2A IN CHRONIC HEPATITIS B: LONG-TERM RESULTS OF A GLOBAL RANDOMIZED CONTROLLED TRIAL

被引：0
|
作者：
Ahn, S. -H. [1 ]
Marcellin, P. [2 ]
Ma, X. [3 ]
Caruntu, F. [4 ]
Tak, W. Y. [5 ]
Elkhashab, M. [6 ]
Chuang, W. -L. [7 ]
Tabak, F. [8 ]
Mehta, R. [9 ]
Petersen, J. [10 ]
Corsa, A. [11 ]
Martins, E. B. [11 ]
Yee, L. J. [11 ]
Dinh, P. [11 ]
Subramanian, G. Mani [11 ]
Buti, M. [12 ]
Gaeta, G. [13 ]
Papatheodoridis, G. [14 ]
Flisiak, R. [15 ]
Chan, H. L. Y. [16 ]
机构：
[1] Yonsei Univ, Coll Med, Seoul, South Korea
[2] Univ Paris Diderot, Hop Beaujon, Clichy, France
[3] Drexel Univ, Coll Med, Philadelphia, PA 19104 USA
[4] Natl Inst Infect Dis Prof Dr Matei Bals, Bucharest, Romania
[5] Kyungpook Natl Univ, Sch Med, Daegu, South Korea
[6] Toronto Liver Ctr, Toronto, ON, Canada
[7] Kaohsiung Med Univ, Chung Ho Mem Hosp, Kaohsiung, Taiwan
[8] Istanbul Univ Cerrahpasa, Fac Med, Istanbul, Turkey
[9] Liver Clin, Surat, India
[10] Univ Hamburg, Hamburg, Germany
[11] Gilead Sci, Foster City, CA USA
[12] Hosp Univ Vall dHebron, Barcelona, Spain
[13] Univ Naples 2, Naples, Italy
[14] Univ Athens, Sch Med, Athens, Greece
[15] Med Univ Bialystok, Bialystok, Poland
[16] Chinese Univ Hong Kong, Hong Kong, Hong Kong, Peoples R China
来源：
JOURNAL OF HEPATOLOGY | 2016年 / 64卷
关键词：
D O I：
10.1016/S0168-8278(16)00924-7
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
FRI-256
引用
收藏
页码：S524 / S525
页数：2
相关论文
共 50 条
  • [1] HBsAg Loss with Tenofovir Disoproxil Fumarate (TDF) plus Peginterferon alfa-2a (PEG) in Chronic Hepatitis B (CHB): Results of a Global Randomized Controlled Trial
    Marcellin, Patrick
    Ahn, Sang Hoon
    Ma, Xiaoli
    Caruntu, Florin A.
    Tak, Won Young
    Elkashab, Magdy
    Chuang, Wan-Long
    Tabak, Fehmi
    Mehta, Rajiv
    Petersen, Joerg
    Martins, Eduardo B.
    Dinh, Phillip
    Corsa, Amoreena C.
    Charuworn, Prista
    Subramanian, Mani
    McHutchison, John G.
    Buti, Maria
    Gaeta, Giovanni B.
    Papatheodoridis, George V.
    Flisiak, Robert
    Chan, Henry Lik-Yuen
    HEPATOLOGY, 2014, 60 : 294A - 295A
  • [2] Hepatitis B surface antigen loss with tenofovir disoproxil fumarate plus peginterferon alpha 2a in chronic hepatitis B: Results of a global randomized controlled trial
    Chan, H.
    Chuang, W. L.
    Lee, C. M.
    Chien, R. N.
    Peng, C. Y.
    Hsu, C. W.
    Chen, C. Y.
    Yang, S. S.
    Marcellin, P.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2015, 30 : 374 - 374
  • [3] Predictors of response to tenofovir disoproxil fumarate plus peginterferon alfa-2a combination therapy for chronic hepatitis B
    Marcellin, P.
    Ahn, S. H.
    Chuang, W. -L.
    Hui, A. J.
    Tabak, F.
    Mehta, R.
    Petersen, J.
    Lee, C. -M.
    Ma, X.
    Caruntu, F. A.
    Tak, W. Y.
    Elkhashab, M.
    Lin, L.
    Wu, G.
    Martins, E. B.
    Charuworn, P.
    Yee, L. J.
    Lim, S. G.
    Foster, G. R.
    Fung, S.
    Morano, L.
    Samuel, D.
    Agarwal, K.
    Idilman, R.
    Strasser, S. I.
    Buti, M.
    Gaeta, G. B.
    Papatheodoridis, G.
    Flisiak, R.
    Chan, H. L. Y.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2016, 44 (09) : 957 - 966
  • [4] Hepatitis B Surface Antigen Loss with Tenofovir Disoproxil Fumarate Plus Peginterferon Alfa-2a: Week 120 Analysis
    Ahn, Sang Hoon
    Marcellin, Patrick
    Ma, Xiaoli
    Caruntu, Florin A.
    Tak, Won Young
    Elkhashab, Magdy
    Chuang, Wan-Long
    Tabak, Fehmi
    Mehta, Rajiv
    Petersen, Joerg
    Guyer, William
    Jump, Belinda
    Chan, Alain
    Subramanian, Mani
    Crans, Gerald
    Fung, Scott
    Buti, Maria
    Gaeta, Giovanni B.
    Hui, Aric J.
    Papatheodoridis, George
    Flisiak, Robert
    Chan, Henry L. Y.
    DIGESTIVE DISEASES AND SCIENCES, 2018, 63 (12) : 3487 - 3497
  • [5] Hepatitis B Surface Antigen Loss with Tenofovir Disoproxil Fumarate Plus Peginterferon Alfa-2a: Week 120 Analysis
    Sang Hoon Ahn
    Patrick Marcellin
    Xiaoli Ma
    Florin A. Caruntu
    Won Young Tak
    Magdy Elkhashab
    Wan-Long Chuang
    Fehmi Tabak
    Rajiv Mehta
    Jörg Petersen
    William Guyer
    Belinda Jump
    Alain Chan
    Mani Subramanian
    Gerald Crans
    Scott Fung
    Maria Buti
    Giovanni B. Gaeta
    Aric J. Hui
    George Papatheodoridis
    Robert Flisiak
    Henry L. Y. Chan
    Digestive Diseases and Sciences, 2018, 63 : 3487 - 3497
  • [6] Correction to: Hepatitis B Surface Antigen Loss with Tenofovir Disoproxil Fumarate Plus Peginterferon Alfa-2a: Week 120 Analysis
    Sang Hoon Ahn
    Patrick Marcellin
    Xiaoli Ma
    Florin A. Caruntu
    Won Young Tak
    Magdy Elkhashab
    Wan-Long Chuang
    Fehmi Tabak
    Rajiv Mehta
    Jörg Petersen
    William Guyer
    Belinda Jump
    Alain Chan
    Mani Subramanian
    Gerald Crans
    Scott Fung
    Maria Buti
    Giovanni B. Gaeta
    Aric J. Hui
    George Papatheodoridis
    Robert Flisiak
    Henry L. Y. Chan
    Digestive Diseases and Sciences, 2019, 64 : 285 - 286
  • [7] Predictors of clinical response: results from a large, randomized controlled study with Tenofovir Disoproxil Fumarate (TDF) plus Peginterferon alfa-2A (PEG) combination for chronic hepatitis B (CHB)
    Strasser, S.
    Chan, H.
    Ahn, S.
    Chuang, W.
    Hui, A.
    Tabak, F.
    Mehta, R.
    Petersen, J.
    Lee, C.
    Ma, X.
    Caruntu, F.
    Tak, W.
    Elkhashab, M.
    Lin, L.
    Dinh, P.
    Martins, E.
    Charuworn, P.
    Mchutchison, J.
    Subramanian, G. M.
    Lim, S.
    Foster, G.
    Fung, S.
    Morano, L.
    Samuel, D.
    Agarwal, K.
    Idilman, R.
    Buti, M.
    Gaeta, G.
    Papatheodoridis, G.
    Flisiak, R.
    Marcellin, P.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2015, 30 : 91 - 92
  • [8] PREDICTORS OF CLINICAL RESPONSE: RESULTS FROM A LARGE, RANDOMIZED CONTROLLED STUDY WITH TENOFOVIR DISOPROXIL FUMARATE (TDF) PLUS PEGINTERFERON ALFA-2A (PEG) COMBINATION FOR CHRONIC HEPATITIS B (CHB)
    Chan, H. L.
    Ahn, S. H.
    Chuang, W. L.
    Hui, A. J.
    Tabak, F.
    Mehta, R.
    Petersen, J.
    Lee, C. -M.
    Ma, X.
    Caruntu, F. A.
    Tak, W. Y.
    Elkhashab, M.
    Lin, L.
    Dinh, P.
    Martins, E. B.
    Charuworn, P.
    McHutchinson, J. G.
    Subramanian, G. M.
    Lim, S. G.
    Foster, G. R.
    Fung, S.
    Morano, L.
    Samuel, D.
    Agarwal, K.
    Idilman, R.
    Strasser, S.
    Buti, M.
    Gaeta, G. B.
    Papatheodoridis, G.
    Flisiak, R.
    Marcellin, P.
    JOURNAL OF HEPATOLOGY, 2015, 62 : S251 - S252
  • [9] Peginterferon alfa-2a plus tenofovir disoproxil fumarate for hepatitis D (HIDIT-II): a randomised, placebo controlled, phase 2 trial
    Wedemeyer, Heiner
    Yurdaydin, Cihan
    Hardtke, Svenja
    Caruntu, Florin Alexandru
    Curescu, Manuela G.
    Yalcin, Kendal
    Akarca, Ulus S.
    Gurel, Selim
    Zeuzem, Stefan
    Erhardt, Andreas
    Lueth, Stefan
    Papatheodoridis, George V.
    Keskin, Onur
    Port, Kerstin
    Radu, Monica
    Celen, Mustafa K.
    Idilman, Ramazan
    Weber, Kristina
    Stift, Judith
    Wittkop, Ulrike
    Heidrich, Benjamin
    Mederacke, Ingmar
    von der Leyen, Heiko
    Dienes, Hans Peter
    Cornberg, Markus
    Koch, Armin
    Manns, Michael P.
    LANCET INFECTIOUS DISEASES, 2019, 19 (03): : 275 - 286
  • [10] Hepatitis B Surface Antigen Loss with Tenofovir Disoproxil Fumarate Plus Peginterferon Alfa-2a: Week 120 Analysis (vol 63, pg 3487, 2018)
    Ahn, Sang Hoon
    Marcellin, Patrick
    Ma, Xiaoli
    Caruntu, Florin A.
    Tak, Won Young
    Elkhashab, Magdy
    Chuang, Wan-Long
    Tabak, Fehmi
    Mehta, Rajiv
    Petersen, Joerg
    Guyer, William
    Jump, Belinda
    Chan, Alain
    Subramanian, Mani
    Crans, Gerald
    Fung, Scott
    Buti, Maria
    Gaeta, Giovanni B.
    Hui, Aric J.
    Papatheodoridis, George
    Flisiak, Robert
    Chan, Henry L. Y.
    DIGESTIVE DISEASES AND SCIENCES, 2019, 64 (01) : 285 - 286
12345